Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Danilkovitch

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Advances in Cancer Research|November 5, 1999
Macrophage stimulating proteinE J Leonard, A Danilkovitch
Journal of Leukocyte Biology|March 18, 1999
Kinases involved in MSP/RON signalingA Danilkovitch, E J Leonard
Apoptosis : an International Journal on Programmed Cell Death|June 5, 2001
Anti-apoptotic action of macrophage stimulating protein (MSP)A Danilkovitch-Miagkova, E J Leonard
Histology and Histopathology|May 3, 2001
Cross-talk between RON receptor tyrosine kinase and other transmembrane receptorsA Danilkovitch-Miagkova, E J Leonard
The Journal of Biological Chemistry|October 9, 1999
Interaction of macrophage-stimulating protein with its receptor. Residues critical for beta chain binding and evidence for independent alpha chain bindingA Danilkovitch, M Miller, E J Leonard
Experimental Cell Research|May 1, 1999
Macrophage stimulating protein-induced epithelial cell adhesion is mediated by a PI3-K-dependent, but FAK-independent mechanismA Danilkovitch, A Skeel, E J Leonard
Hybridoma|February 1, 1997
Anti-tumor activity of synthetic peptide fragments of the human interferon-alpha 2A Danilkovitch, K Freze, J Romashkova, et al.
Molecular and Cellular Biology|February 25, 2000
Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cellsA Danilkovitch, S Donley, A Skeel, et al.
The Journal of Biological Chemistry|March 30, 2001
Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathwayA V Ivanova, S V Ivanov, A Danilkovitch-Miagkova, et al.
Molecular and Cellular Biology|August 4, 2001
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathwayA Danilkovitch-Miagkova, A Miagkov, A Skeel, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Advances in Cancer Research|November 5, 1999
Macrophage stimulating proteinE J Leonard, A Danilkovitch
Journal of Leukocyte Biology|March 18, 1999
Kinases involved in MSP/RON signalingA Danilkovitch, E J Leonard
Apoptosis : an International Journal on Programmed Cell Death|June 5, 2001
Anti-apoptotic action of macrophage stimulating protein (MSP)A Danilkovitch-Miagkova, E J Leonard
Histology and Histopathology|May 3, 2001
Cross-talk between RON receptor tyrosine kinase and other transmembrane receptorsA Danilkovitch-Miagkova, E J Leonard
The Journal of Biological Chemistry|October 9, 1999
Interaction of macrophage-stimulating protein with its receptor. Residues critical for beta chain binding and evidence for independent alpha chain bindingA Danilkovitch, M Miller, E J Leonard
Experimental Cell Research|May 1, 1999
Macrophage stimulating protein-induced epithelial cell adhesion is mediated by a PI3-K-dependent, but FAK-independent mechanismA Danilkovitch, A Skeel, E J Leonard
Hybridoma|February 1, 1997
Anti-tumor activity of synthetic peptide fragments of the human interferon-alpha 2A Danilkovitch, K Freze, J Romashkova, et al.
Molecular and Cellular Biology|February 25, 2000
Two independent signaling pathways mediate the antiapoptotic action of macrophage-stimulating protein on epithelial cellsA Danilkovitch, S Donley, A Skeel, et al.
The Journal of Biological Chemistry|March 30, 2001
Regulation of STRA13 by the von Hippel-Lindau tumor suppressor protein, hypoxia, and the UBC9/ubiquitin proteasome degradation pathwayA V Ivanova, S V Ivanov, A Danilkovitch-Miagkova, et al.
Molecular and Cellular Biology|August 4, 2001
Oncogenic mutants of RON and MET receptor tyrosine kinases cause activation of the beta-catenin pathwayA Danilkovitch-Miagkova, A Miagkov, A Skeel, et al.
Pageof 2